Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal - Nasdaq

1 min to read

Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal – Nasdaq

Tags: SPACs

e.GO's Registration Statement on Form F-4 in Connection With Its … – Business Wire

e.GO's Registration Statement on Form F-4 in Connection With Its ... Business Wire Source: e.GO's Registration Statement on Form F-4 in...
26 Capital Acquisition Corp. Announces Liquidation – PR Newswire

26 Capital Acquisition Corp. Announces Liquidation PR Newswire Source: 26 Capital Acquisition Corp. Announces Liquidation - PR Newswire
Athena Consumer Acquisition Corp. Announces Extension of … – WDRB

Athena Consumer Acquisition Corp. Announces Extension of ... WDRB Source: Athena Consumer Acquisition Corp. Announces Extension of ... - WDRB
Demandbase Announces New Executive Hires with Industry … – PR Newswire

Demandbase Announces New Executive Hires with Industry ... PR Newswire Source: Demandbase Announces New Executive Hires with Industry ... - PR...
Debt restructuring "will do little to fix Cazoo's rickety engine" – AM

Debt restructuring "will do little to fix Cazoo's rickety engine" AM Source: Debt restructuring "will do little to fix Cazoo's rickety...